美国糖尿病视网膜病变诊疗服务可及性的地理分布:AAO IRIS注册分析
发现城市诊所承担了67%–80%的操作(调整人口后)及65%–90%(调整疾病负担后),非城市地区服务可及性显著较低。
要点
- 城市诊所执行了大多数DR诊疗操作,非城市地区仅贡献1%–35%。
- 非城市诊所中,综合眼科医生承担超过35%的IVI和PRP,而城市仅约5%–7%。
- 超过93%的非城市居民和超过97%的城市居民在城市诊所接受治疗。
核心结论
- 糖尿病视网膜病变相关诊疗服务集中于城市诊所,即使调整人口差异和疾病负担后仍如此。
- 结果支持需要改善非城市社区的可及性策略。
主要发现
- 城市诊所在调整人口差异后执行67%–80%的操作,调整疾病负担后执行65%–90%,非城市站点仅贡献1%–35%。
- 非城市诊所中综合眼科医生执行超过35%的IVI和PRP,城市诊所中仅约5%–7%。
- 超过93%的非城市居民和超过97%的城市居民在城市诊所接受治疗操作。
- 非城市居民PDR患病率更高(18.21% vs. 16.02%),且所有治疗操作率更高。
- 在城市诊所接受治疗者中,47.7%存在超过1年的OCT间隔,非城市诊所者为44.1%。
临床怎么用
- 需关注非城市地区糖尿病视网膜病变诊疗服务可及性不足的问题。
- 非城市诊所中综合眼科医生承担较多IVI和PRP操作,提示其在该类服务中的重要作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate access to diabetic retinopathy (DR) care by quantifying the geographic distribution of therapeutic and diagnostic procedures for DR across the United States. DESIGN: Retrospective cohort study. PARTICIPANTS: Using the IRIS® Registry (Intelligent Research in Sight), we identified patients with 2 or more International Classification of Diseases codes for DR between January 1, 2013, and December 31, 2024. METHODS: Care was classified as therapeutic (intravitreal injections [IVIs], panretinal photocoagulation [PRP], focal laser photocoagulation, and pars plana vitrectomy) or diagnostic (OCT, fundus photography, and fluorescein angiography) by Current Procedural Terminology codes. Urban versus nonurban practice locations were defined using the United States Department of Agriculture Rural-Urban Commuting Area codes. Procedure volume, population-adjusted and disease-adjusted rates, and physician subspecialty distributions were compared across settings. A subanalysis examined disease burden, DR care adherence, and diabetic macular edema management among nonurban residents stratified by treating practice urbanization and sociodemographic factors. MAIN OUTCOME MEASURES: Likelihood of each diagnostic and therapeutic procedure occurring in urban areas. RESULTS: We identified 11 254 015 therapeutic and 35 892 574 diagnostic procedures undergone by 1 142 505 patients with DR. Urban practices performed 67% to 80% of all procedures after adjusting for population differences, and 65% to 90% after adjusting for disease burden, with nonurban sites contributing only 1% to 35% across categories. In nonurban practices, comprehensive ophthalmologists performed more than 35% of IVI and PRP procedures, whereas in urban practices, they performed roughly 5% to 7% of these procedures. More than 93% of nonurban residents and more than 97% of urban residents received therapeutic procedures in urban practices. Nonurban residents showed a higher PDR prevalence (18.21% vs. 16.02%) and higher rates of all therapeutic procedures. Of those receiving care at urban practices, 47.7% had a more than 1-year OCT gap versus 44.1% at nonurban practices; this increase in discontinuity was disproportionately larger among older patients, Black patients, and those with lower household incomes. CONCLUSIONS: Diabetic retinopathy-related diagnostic and therapeutic services were concentrated in urban practice locations, even after adjustment for population differences and disease burden. This finding supports the need for strategies to improve access in nonurban communities. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
引用
- Parmar UPS, Fujita A, Lokhande A, et al. Geographic Distribution of Access to Diabetic Retinopathy Care in the United States: An American Academy of Ophthalmology IRIS® Registry Analysis. Ophthalmology. 2026. PMID: 42457090. doi:10.1016/j.ophtha.2026.07.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。